Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Grisham

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Nature Biotechnology|September 6, 2000
New rules for gene patentsJ Grisham
Annals of Emergency Medicine|January 1, 1994
ACEP policy statement on pediatric sedation and analgesicJ Grisham
Nature Biotechnology|August 10, 2000
Genomics company formed from Framingham heart studyJ Grisham
Nature Biotechnology|June 3, 2000
Protein biopesticide may be next wave in pest controlJ Grisham
Nature Biotechnology|March 4, 2000
Inquiry into gene therapy widensJ Grisham
Nature Biotechnology|April 5, 2000
Three-way merger regenerates new companyJ Grisham
Annals of Emergency Medicine|October 1, 1991
Bone marrow aspirate as an accessible and reliable source for critical laboratory studiesJ Grisham, C Hastings
Nursing Outlook|January 1, 1986
Health in the balanceS Couser, G Daly, J Grisham, et al.
Archives of Surgery (Chicago, Ill. : 1960)|October 1, 1979
A clinical and laboratory evaluation of a polyurethane foam: a new donor site dressingR E Salisbury, A G Bevin, G P Dingeldein, et al.
Genes & Development|February 1, 1996
Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regenerationH Wu, M Wade, L Krall, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Nature Biotechnology|September 6, 2000
New rules for gene patentsJ Grisham
Annals of Emergency Medicine|January 1, 1994
ACEP policy statement on pediatric sedation and analgesicJ Grisham
Nature Biotechnology|August 10, 2000
Genomics company formed from Framingham heart studyJ Grisham
Nature Biotechnology|June 3, 2000
Protein biopesticide may be next wave in pest controlJ Grisham
Nature Biotechnology|March 4, 2000
Inquiry into gene therapy widensJ Grisham
Nature Biotechnology|April 5, 2000
Three-way merger regenerates new companyJ Grisham
Annals of Emergency Medicine|October 1, 1991
Bone marrow aspirate as an accessible and reliable source for critical laboratory studiesJ Grisham, C Hastings
Nursing Outlook|January 1, 1986
Health in the balanceS Couser, G Daly, J Grisham, et al.
Archives of Surgery (Chicago, Ill. : 1960)|October 1, 1979
A clinical and laboratory evaluation of a polyurethane foam: a new donor site dressingR E Salisbury, A G Bevin, G P Dingeldein, et al.
Genes & Development|February 1, 1996
Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regenerationH Wu, M Wade, L Krall, et al.
Pageof 3